Xiaoyuan (Shawn) Chen, PhD, Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD
Thursday, October 19, 2017, 12:00 PM Eppley Science Hall (ESH 3010)
Theranostics (Rx/Dx) aims to develop molecular diagnostic tests and targeted therapeutics with the goals of individualizing treatment by targeting therapy to an individual's specific disease subtype and genetic profile. It can be diagnosis followed by therapy to stratify patients who will likely respond to a given treatment; it can also be therapy followed by diagnosis to monitor early response to treatment and predict treatment efficacy; it is also possible that diagnostics and therapeutics are co-developed (nanotheranostics). This talk will give examples of optotheranostics, magnetotheranostics and immunotheranostics. The translational potential of Nanotheranostics will also be briefly discussed.
NanoDDS'17 will be held September 22-24, 2017 at the University of Michigan, Ann Arbor.
Visit www.nanodds2017.org for more details!
Howard Gendelman, M.D., professor and chair of the UNMC Department of Pharmacology and Experimental Neuroscience, received the Humanitarian of the Year Award from the Jewish Federation of...
Mike Boska, Ph.D., whose expertise in magnetic resonance imaging research benefited countless scientists at UNMC, died Saturday (May 13...